{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T22:13:29Z","timestamp":1787609609569,"version":"build-2736575974"},"reference-count":23,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["K08DK115883"],"award-info":[{"award-number":["K08DK115883"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["DK10596"],"award-info":[{"award-number":["DK10596"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1TR002649"],"award-info":[{"award-number":["UL1TR002649"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"NIAAA","doi-asserted-by":"publisher","award":["1U01AA026979"],"award-info":[{"award-number":["1U01AA026979"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005347","name":"AASLD","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008272","name":"Novartis Pharmaceuticals Corporation","doi-asserted-by":"publisher","award":["5U01AA021883-04"],"award-info":[{"award-number":["5U01AA021883-04"]}],"id":[{"id":"10.13039\/100008272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008272","name":"Novartis Pharmaceuticals Corporation","doi-asserted-by":"publisher","award":["5U01AA021788-04"],"award-info":[{"award-number":["5U01AA021788-04"]}],"id":[{"id":"10.13039\/100008272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008272","name":"Novartis Pharmaceuticals Corporation","doi-asserted-by":"publisher","award":["5U01AA021840-04"],"award-info":[{"award-number":["5U01AA021840-04"]}],"id":[{"id":"10.13039\/100008272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008272","name":"Novartis Pharmaceuticals Corporation","doi-asserted-by":"publisher","award":["5U01AA021891-04"],"award-info":[{"award-number":["5U01AA021891-04"]}],"id":[{"id":"10.13039\/100008272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017784","name":"Gilead Research Scholars Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017784","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lipidjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.jacl.2021.10.002","type":"journal-article","created":{"date-parts":[[2021,10,22]],"date-time":"2021-10-22T02:34:17Z","timestamp":1634870057000},"page":"805-813","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Circulating high density lipoprotein distinguishes alcoholic hepatitis from heavy drinkers and predicts 90-day outcome"],"prefix":"10.1016","volume":"15","author":[{"given":"Karan","family":"Mathur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Vilar-Gomez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margery A.","family":"Connelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanchang","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun J.","family":"Sanyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naga","family":"Chalasani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0495-9940","authenticated-orcid":false,"given":"Z. Gordon","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacl.2021.10.002_bib0001","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S0016-5085(85)80155-4","article-title":"Role of the liver in the degradation of lipoproteins","volume":"88","author":"Cooper","year":"1985","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jacl.2021.10.002_bib0002","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/MOL.0000000000000569","article-title":"Lipoprotein metabolism in liver diseases","volume":"30","author":"Perez-Matos","year":"2019","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.jacl.2021.10.002_bib0003","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1530-0277.1984.tb05689.x","article-title":"Ethanol and lipids","volume":"8","author":"Lieber","year":"1984","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.jacl.2021.10.002_bib0004","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1161\/CIRCGENETICS.109.873604","article-title":"Alcohol intake, myocardial infarction, biochemical risk factors, and alcohol dehydrogenase genotypes","volume":"2","author":"Tolstrup","year":"2009","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.jacl.2021.10.002_bib0005","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.atherosclerosis.2016.12.008","article-title":"The causal effects of alcohol on lipoprotein subfraction and triglyceride levels using a Mendelian randomization analysis: The Nagahama study","volume":"257","author":"Tabara","year":"2017","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2021.10.002_bib0006","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1161\/01.CIR.102.19.2347","article-title":"Alcohol consumption raises HDL cholesterol levels by increasing the transport rate of apolipoproteins A-I and A-II","volume":"102","author":"De Oliveira","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2021.10.002_bib0007","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nrgastro.2015.35","article-title":"Alcoholic liver disease: mechanisms of injury and targeted treatment","volume":"12","author":"Louvet","year":"2015","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jacl.2021.10.002_bib0008","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1093\/alcalc\/agz036","article-title":"Alcoholic Hepatitis: A Review","volume":"54","author":"Hosseini","year":"2019","journal-title":"Alcohol Alcohol"},{"key":"10.1016\/j.jacl.2021.10.002_bib0009","doi-asserted-by":"crossref","first-page":"e8742","DOI":"10.1097\/MD.0000000000008742","article-title":"Hemolytic anemia in alcoholic liver disease: Zieve syndrome: A case report and literature review","volume":"96","author":"Liu","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jacl.2021.10.002_bib0010","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1177\/107424840501000106","article-title":"Evaluation of methods for the measurement of low-density lipoprotein cholesterol","volume":"10","author":"Bairaktari","year":"2005","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"10.1016\/j.jacl.2021.10.002_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/S0002-9149(02)02632-2","article-title":"Measurement issues related to lipoprotein heterogeneity","volume":"90","author":"Otvos","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacl.2021.10.002_bib0012","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9092915","article-title":"Characterization of LP-Z Lipoprotein Particles and Quantification in Subjects with Liver Disease Using a Newly Developed NMR-Based Assay","volume":"9","author":"Bedi","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.jacl.2021.10.002_bib0013","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.cll.2006.07.006","article-title":"Lipoprotein particle analysis by nuclear magnetic resonance spectroscopy","volume":"26","author":"Jeyarajah","year":"2006","journal-title":"Clin Lab Med"},{"key":"10.1016\/j.jacl.2021.10.002_bib0014","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1053\/j.gastro.2016.02.042","article-title":"Standard Definitions and Common Data Elements for Clinical Trials in Patients With Alcoholic Hepatitis: Recommendation From the NIAAA Alcoholic Hepatitis Consortia","volume":"150","author":"Crabb","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jacl.2021.10.002_bib0015","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.clinbiochem.2014.07.015","article-title":"NMR measurement of LDL particle number using the Vantera Clinical Analyzer","volume":"47","author":"Matyus","year":"2014","journal-title":"Clinical Biochem"},{"key":"10.1016\/j.jacl.2021.10.002_bib0016","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1373\/clinchem.2014.232918","article-title":"GlycA: A Composite Nuclear Magnetic Resonance Biomarker of Systemic Inflammation","volume":"61","author":"Otvos","year":"2015","journal-title":"Clin Chem"},{"key":"10.1016\/j.jacl.2021.10.002_bib0017","doi-asserted-by":"crossref","first-page":"k2817","DOI":"10.1136\/bmj.k2817","article-title":"Mortality due to cirrhosis and liver cancer in the United States, 1999-2016: observational study","volume":"362","author":"Tapper","year":"2018","journal-title":"Bmj"},{"key":"10.1016\/j.jacl.2021.10.002_bib0018","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s11883-012-0230-7","article-title":"Effects of ethanol intake on lipoproteins","volume":"14","author":"Brinton","year":"2012","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.jacl.2021.10.002_bib0019","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1111\/liv.13076","article-title":"Steatohepatitis and liver fibrosis are predicted by the characteristics of very low density lipoprotein in nonalcoholic fatty liver disease","volume":"36","author":"Jiang","year":"2016","journal-title":"Liver Int"},{"key":"10.1016\/j.jacl.2021.10.002_bib0020","doi-asserted-by":"crossref","first-page":"31965","DOI":"10.1074\/jbc.M110.126292","article-title":"Influence of apolipoprotein (Apo) A-I structure on nascent high density lipoprotein (HDL) particle size distribution","volume":"285","author":"Vedhachalam","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jacl.2021.10.002_bib0021","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s10620-017-4862-x","article-title":"Abnormalities of Lipoprotein Levels in Liver Cirrhosis: Clinical Relevance","volume":"63","author":"Privitera","year":"2018","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jacl.2021.10.002_bib0022","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1001\/archinte.1997.00440280120012","article-title":"Serum lipid and lipoprotein patterns in patients with liver cirrhosis and chronic active hepatitis","volume":"157","author":"Cicognani","year":"1997","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacl.2021.10.002_bib0023","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jhep.2020.01.026","article-title":"HDL-related biomarkers are robust predictors of survival in patients with chronic liver failure","volume":"73","author":"Trieb","year":"2020","journal-title":"J Hepatol"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287421002531?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287421002531?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T08:17:31Z","timestamp":1778833051000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933287421002531"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S1933287421002531"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2021.10.002","relation":{},"ISSN":["1933-2874"],"issn-type":[{"value":"1933-2874","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Circulating high density lipoprotein distinguishes alcoholic hepatitis from heavy drinkers and predicts 90-day outcome","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Lipidology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacl.2021.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 National Lipid Association. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}